MetLife, Inc.

NYSE:MET Stok Raporu

Piyasa değeri: US$55.1b

MetLife Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

MetLife şirketinin kazançları yıllık ortalama -8% oranında azalırken, Insurance sektörünün kazançları yıllık 14.6% oranında artan oldu. Gelirler yıllık ortalama 1.9% oranında artan oldu. MetLife şirketinin öz sermaye getirisi 13% olup, net marjı 4.4% dir.

Anahtar bilgiler

-8.02%

Kazanç büyüme oranı

-1.48%

EPS büyüme oranı

Insurance Sektör Büyümesi8.02%
Gelir büyüme oranı1.87%
Özkaynak getirisi13.00%
Net Marj4.43%
Son Kazanç Güncellemesi31 Mar 2026

Yakın geçmiş performans güncellemeleri

Recent updates

Anlatı Güncellemesi Jun 09

MET: Capital Returns And Product Flexibility Will Shape Future Risk Reward Balance

Analysts have raised their price target on MetLife to $92.80 from $89.31, citing updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E estimates. What's in the News MetLife reported Q1 2026 adjusted earnings growth of 18% year over year, with broad top line growth across all operating segments and resilient margins, supported by expanding businesses in Asia, Latin America, Group Benefits, and Retirement and Income Solutions.
Seeking Alpha Jun 08

MetLife: Not Exciting, But It Works

Summary MetLife delivers strong Q1 2026 results with adjusted EPS up 23% to $2.42 and ROE at 17%, highlighting robust core performance. I find MET's fixed-income preferreds, especially Series F, compelling with yields near 6.5% and payout ratios under 4%, offering rare quality and safety. Common shares trade at a fair 8.5x forward P/E with limited near-term upside; total equity returns approximate 8% annually via buybacks and dividends. Key risks include commercial mortgage exposure and volatile alternative investment income, but preferred dividend coverage remains exceptionally strong. Read the full article on Seeking Alpha
Anlatı Güncellemesi May 03

MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential

Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.
Anlatı Güncellemesi Apr 17

MET: Share Repurchases Following Index Exit Will Support Future Upside Potential

Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).
Anlatı Güncellemesi Apr 01

MET: Share Repurchases And Index Exit Will Shape Future Upside Potential

Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.
Anlatı Güncellemesi Mar 18

MET: Share Repurchases Will Support Future Upside Potential

Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).
Anlatı Güncellemesi Mar 04

MET: Buybacks And Retirement Income Agreements Will Drive Future Upside

Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.
Anlatı Güncellemesi Dec 16

MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power

Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.
Anlatı Güncellemesi Nov 07

MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements

Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.
Anlatı Güncellemesi Oct 24

Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead

Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.
Anlatı Güncellemesi Oct 09

International Demand And Digital Transformation Will Fuel Success

Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.
Anlatı Güncellemesi Sep 04

International Demand And Digital Transformation Will Fuel Success

With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.
Analiz Makalesi Jun 11

It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year

Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...
Seeking Alpha Feb 11

MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart

Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking Alpha
Seeking Alpha Nov 26

MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential

Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking Alpha
Seeking Alpha Sep 23

MetLife: One Of The Best Life Insurance Stocks

Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking Alpha
Seeking Alpha Jul 09

Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield

Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking Alpha
Seeking Alpha Jun 26

MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood

Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking Alpha
Seeking Alpha Apr 18

MetLife: Healthy But Lacks Clear Advantages

Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking Alpha

Gelir ve Gider Dağılımı

MetLife nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NYSE:MET Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Mar 2677,5843,43400
31 Dec 2577,0793,17300
30 Sep 2571,9323,63400
30 Jun 2573,0114,09100
31 Mar 2573,4944,30500
31 Dec 2470,9824,22600
30 Sep 2471,3403,56100
30 Jun 2468,7672,70800
31 Mar 2467,5702,16600
31 Dec 2366,9011,38000
30 Sep 2363,4792,35500
30 Jun 2369,8963,03100
31 Mar 2368,7473,54200
31 Dec 2268,7645,09900
30 Sep 2273,2514,72600
30 Jun 2267,8735,14900
31 Mar 2270,9237,63400
31 Dec 2168,6886,65400
30 Sep 2170,4095,30100
30 Jun 2169,5194,41300
31 Mar 2165,0941,11500
31 Dec 2067,8425,19100
30 Sep 2065,5675,60300
30 Jun 2068,2307,12200
31 Mar 2071,6288,73800
31 Dec 1969,6205,72100
30 Sep 1968,1397,19500
30 Jun 1965,7505,92300
31 Mar 1969,4385,08400
31 Dec 1867,9414,98200
30 Sep 1868,1125,244-2520
30 Jun 1867,9805,235-1660
31 Mar 1862,1195,19700
31 Dec 1762,3084,89300
30 Sep 1759,2631,893-330
30 Jun 1758,9082,044-280
31 Mar 1757,2632,229-970
31 Dec 1660,7323,48100
30 Sep 1665,2094,9943680
30 Jun 1667,2555,1693550
31 Mar 1669,9525,2193420
31 Dec 1561,2573,89100
30 Sep 1571,8885,8573330
30 Jun 1572,6776,7243500

Kaliteli Kazançlar: MET yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: MET 'nin mevcut net kar marjları (4.4%) geçen yılın (5.9%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: MET şirketinin kazançları son 5 yılda yılda 8% oranında azaldı.

Büyüme Hızlandırma: MET 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: MET geçtiğimiz yıl negatif kazanç büyümesine ( -20.2% ) sahipti ve bu da onu Insurance sektör ortalamasıyla ( 36.5% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: MET 'nin Özsermaye Getirisi ( 13% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/06/10 22:03
Gün Sonu Hisse Fiyatı2026/06/10 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

MetLife, Inc. 31 Bu analistlerden 9, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Jacob KilsteinArgus Research Company
Jay GelbBarclays
Taylor ScottBarclays